1. Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol. 2012; 5:852–62.
2. Rindi G, Klimstra DS, Arnold R, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press;2010. p. 13–4.
3. Gui X, Qin L, Gao ZH, Falck V, Harpaz N. Goblet cell carcinoids at extraappendiceal locations of gastrointestinal tract: an underrecognized diagnostic pitfall. J Surg Oncol. 2011; 103:790–5.
Article
4. Hofler H, Kloppel G, Heitz PU. Combined production of mucus, amines and peptides by goblet-cell carcinoids of the appendix and ileum. Pathol Res Pract. 1984; 178:555–61.
5. Stancu M, Wu TT, Wallace C, Houlihan PS, Hamilton SR, Rashid A. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol. 2003; 16:1189–98.
Article
6. Yamabuki T, Omi M, Yonemori A, et al. Goblet cell carcinoid of the rectum with lymph node metastasis: report of a case. Surg Today. 2011; 41:1284–9.
Article
7. Gregersen T, Holt N, Gronbaek H, Vogel I, Jørgensen LJ, Krogh K. Goblet cell carcinoid in a patient with neurofibromatosis type 1: a rare combination. Case Rep Gastrointest Med. 2012; 2012:185730.
Article
8. Maertens O, Prenen H, Debiec-Rychter M, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet. 2006; 15:1015–23.
Article
9. Stewart W, Traynor JP, Cooke A, et al. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. Fam Cancer. 2007; 6:147–52.
Article